The role of nitric oxide in vascular headache
- PMID: 12964492
- DOI: 10.1023/a:1024800512790
The role of nitric oxide in vascular headache
Abstract
Shortly after the invention of nitroglycerin (NTG), it was noticed that this substance is capable of inducing a violent headache. Only recently, it became known that this was due to the release of nitric oxide (NO) by NTG. As the molecular mechanism of migraine pain remains to be determined, NTG, being pro-drug for NO, has been used to study the aetiology and pathophysiology of migraine. Such studies with NTG- and also histamine-induced headaches, have led to propose that NO may be the causative molecule in migraine pain. The evidence supporting the role of NO in migraine is discussed, e.g. substances capable of inducing experimental vascular headache do so with NO as the common mediator, while drugs with antimigraine activity inhibit NO and the cascade of intracellular reactions triggered by NO. The importance of NO as a potential initiator of the migraine attack opens new directions for the pharmacological treatment of migraine and other vascular headaches.
Similar articles
-
The nitric oxide hypothesis of migraine and other vascular headaches.Cephalalgia. 1995 Apr;15(2):94-100. doi: 10.1046/j.1468-2982.1995.015002094.x. Cephalalgia. 1995. PMID: 7641257
-
Nitroglycerin-induced headache is not dependent on histamine release: support for a direct nociceptive action of nitric oxide.Cephalalgia. 1994 Dec;14(6):437-42. doi: 10.1046/j.1468-2982.1994.1406437.x. Cephalalgia. 1994. PMID: 7535192 Clinical Trial.
-
Nitric oxide is a key molecule in migraine and other vascular headaches.Trends Pharmacol Sci. 1994 May;15(5):149-53. doi: 10.1016/0165-6147(94)90075-2. Trends Pharmacol Sci. 1994. PMID: 7538702 Review.
-
[Nitroglycerin-induced headaches].Orv Hetil. 2004 Nov 14;145(46):2323-8. Orv Hetil. 2004. PMID: 16106903 Hungarian.
-
Nitric oxide theory of migraine.Clin Neurosci. 1998;5(1):28-33. Clin Neurosci. 1998. PMID: 9523055 Review.
Cited by
-
Nitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology.J Biomed Biotechnol. 2004;2004(4):227-237. doi: 10.1155/S1110724304402034. J Biomed Biotechnol. 2004. PMID: 15467163 Free PMC article.
-
Headache-type adverse effects of NO donors: vasodilation and beyond.Br J Pharmacol. 2010 May;160(1):20-35. doi: 10.1111/j.1476-5381.2010.00643.x. Epub 2010 Mar 19. Br J Pharmacol. 2010. PMID: 20331608 Free PMC article. Review.
-
Episodic dural stimulation in awake rats: a model for recurrent headache.Headache. 2007 Jul-Aug;47(7):1026-36. doi: 10.1111/j.1526-4610.2007.00871.x. Headache. 2007. PMID: 17635594 Free PMC article.
-
High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients.Neurol Sci. 2017 Jul;38(7):1287-1291. doi: 10.1007/s10072-017-2970-1. Epub 2017 Apr 28. Neurol Sci. 2017. PMID: 28455769
-
A Bidirectional View of Migraine and Diet Relationship.Neuropsychiatr Dis Treat. 2021 Feb 11;17:435-451. doi: 10.2147/NDT.S282565. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 33603381 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials